(Q44173964)

30 November 2017

Protective effect of the antiepileptic drug candidate talampanel against AMPA-induced striatal neurotoxicity in neonatal rats (English)

1 reference

30 November 2017

1 reference

1 reference

1 reference

Ildikó Világi

1

1 reference

30 November 2017

József Takács

2

1 reference

30 November 2017

Attila Gulyás-Kovács

3

1 reference

30 November 2017

Ilona Banczerowski-Pelyhe

4

1 reference

30 November 2017

István Tarnawa

5

1 reference

30 November 2017

1 October 2002

1 reference

30 November 2017

Brain Research Bulletin

1 reference

30 November 2017

59

1 reference

30 November 2017

1

1 reference

30 November 2017

35-40

1 reference

New non competitive AMPA antagonists

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Role of desensitization of AMPA receptors on the neuronal viability and on the [Ca2+]ichanges in cultured rat hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

GYKI 52466 blocks the increase in extracellular glutamate induced by ischaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Talampanel, a novel noncompetitive AMPA antagonist, is neuroprotective after traumatic brain injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V).

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Neuropharmacology of AMPA and kainate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Ligands for glutamate receptors: design and therapeutic prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Synaptic transmission in the striatum: from plasticity to neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Effect of a glutamate receptor antagonist (GYKI 52466) on 4-aminopyridine-induced seizure activity developed in rat cortical slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Bimoclomol protects against vascular consequences of experimental subarachnoid hemorrhage in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Hypoxia-ischemia in the neonatal rat brain: histopathology after post-treatment with NMDA and non-NMDA receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Negative allosteric modulators of AMPA-preferring receptors inhibit [(3)H]GABA release in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Stereotaxic operation in the neonatal rat; a novel and simple procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

AMPA receptor mediated excitotoxicity in neocortical neurons is developmentally regulated and dependent upon receptor desensitization.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Comparison of neuroprotective efficacy of competitive and non-competitive AMPA antagonists in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Effects of alpha(2)-adrenoceptor agonists on perinatal excitotoxic brain injury: comparison of clonidine and dexmedetomidine

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

The non-NMDA antagonists, NBQX and GYKI 52466, protect against cortical and striatal cell loss following transient global ischaemia in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

In vivo, the direct and seizure-induced neuronal cytotoxicity of kainate and AMPA is modified by the non-competitive antagonist, GYKI 52466.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Novel injury mechanism in anoxia and trauma of spinal cord white matter: glutamate release via reverse Na+-dependent glutamate transport.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

The non-competitive AMPA antagonist LY 300168 (GYKI 53655) attenuates AMPA-induced hippocampal injury in neonatal rodents.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Stereoselective effects-of 2,3-benzodiazepines in vivo: electrophysiology and neuroprotection studies

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

GYKI 52466 protects against non-NMDA receptor-mediated excitotoxicity in primary rat hippocampal cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Stereoselective neuroprotection by novel 2,3-benzodiazepine non-competitive AMPA antagonist against non-NMDA receptor-mediated excitotoxicity in primary rat hippocampal cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

The selective ionotropic-type quisqualate receptor agonist AMPA is a potent neurotoxin in immature rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Susceptibility of brain to AMPA induced excitotoxicity transiently peaks during early postnatal development

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Non-NMDA antagonists protect against kainate more than AMPA toxicity in the rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

The neuroprotective effects of non-NMDA antagonists in the cerebellum of the spastic Han Wistar mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Glutamate in CNS disorders as a target for drug development: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

CGS-19755 and MK-801 selectively prevent rat striatal cholinergic and gabaergic neuronal degeneration induced by N-methyl-D-aspartate and ibotenate in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Hypoxia, excitotoxicity, and neuroprotection in the hippocampal slice preparation

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, GYKI 52466, after focal ischemia in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Autoimmune encephalomyelitis ameliorated by AMPA antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Comparison of anticonvulsive and acute neuroprotective activity of three 2,3-benzodiazepine compounds, GYKI 52466, GYKI 53405, and GYKI 53655.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Effect of glutamate receptor antagonists on excitatory postsynaptic potentials in striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Perinatal brain injury: from pathogenesis to neuroprotection

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2802%2900835-3

7 January 2021

10.1016/S0361-9230(02)00835-3

Identifiers

DOI

1 reference

30 November 2017

1 reference